Article Details
Retrieved on: 2024-03-15 14:30:33
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the significant growth in the monoclonal antibody therapeutics market, driven by technological advancements in biotechnology and the increasing demand for personalized medicine, particularly in treating chronic diseases like cancer and autoimmune disorders. Major players like Roche and AstraZeneca are mentioned, highlighting the market's potential expansion.
Article found on: www.prnewswire.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here